Additionally, serum leptin increment was significantly associated with systemic inflammation during phase of exacerbation, and higher levels of leptin (and IL-6) in lungs and serum were associated with the severity of COPD-TS in patients and in rat models [31, 32]. This evidence concerns the gene IL6 and Timothy syndrome.